236 related articles for article (PubMed ID: 27009283)
1. The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model.
Zhao J; Liu T; Liu E; Li G; Qi L; Li J
J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320315627409. PubMed ID: 27009283
[TBL] [Abstract][Full Text] [Related]
2. Effects of the angiotensin-(1-7)/Mas/PI3K/Akt/nitric oxide axis and the possible role of atrial natriuretic peptide in an acute atrial tachycardia canine model.
Zhao J; Liu E; Li G; Qi L; Li J; Yang W
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1069-77. PubMed ID: 25143331
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs.
Liu E; Yang S; Xu Z; Li J; Yang W; Li G
Regul Pept; 2010 Jun; 162(1-3):73-8. PubMed ID: 20074590
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) attenuates atrial tachycardia-induced sympathetic nerve remodeling.
Shangguan W; Shi W; Li G; Wang Y; Li J; Wang X
J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317729281. PubMed ID: 28877652
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.
Shah A; Gul R; Yuan K; Gao S; Oh YB; Kim UH; Kim SH
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1365-74. PubMed ID: 20190099
[TBL] [Abstract][Full Text] [Related]
6. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
Liu E; Xu Z; Li J; Yang S; Yang W; Li G
Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
[TBL] [Abstract][Full Text] [Related]
7. Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation.
Wang X; Li G
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318755269. PubMed ID: 29378480
[TBL] [Abstract][Full Text] [Related]
8. Cilostazol ameliorates atrial ionic remodeling in long-term rapid atrial pacing dogs.
Zhao Z; Li W; Wang X; Chen Y; Li J; Yang W; Cheng L; Liu E; Liu T; Li G
Anatol J Cardiol; 2015; 15(12):963-9. PubMed ID: 25880049
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
Wang X; Li G
Pacing Clin Electrophysiol; 2014 Oct; 37(10):1349-56. PubMed ID: 24861429
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) prevents atrial tachycardia induced-heat shock protein 27 expression.
Wang X; Shangguan W; Li G
J Electrocardiol; 2018; 51(1):117-120. PubMed ID: 29056233
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental atrial fibrillation in a canine model of rapid atrial pacing by the phosphodiesterase 3 inhibitor cilostazol.
Zhao Z; Li R; Wang X; Li J; Xu X; Liu T; Liu E; Li G
J Electrocardiol; 2020; 60():151-158. PubMed ID: 32371198
[TBL] [Abstract][Full Text] [Related]
12. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K
Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs.
Laurent G; Leong-Poi H; Mangat I; Moe GW; Hu X; So PP; Tarulli E; Ramadeen A; Rossman EI; Hennan JK; Dorian P
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):171-8. PubMed ID: 19808462
[TBL] [Abstract][Full Text] [Related]
14. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.
Nakatani Y; Nishida K; Sakabe M; Kataoka N; Sakamoto T; Yamaguchi Y; Iwamoto J; Mizumaki K; Fujiki A; Inoue H
J Am Coll Cardiol; 2013 Feb; 61(5):582-8. PubMed ID: 23273396
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of ANP by angiotensin-(1-9) via the angiotensin type 2 receptor.
Cha SA; Park BM; Gao S; Kim SH
Life Sci; 2013 Dec; 93(24):934-40. PubMed ID: 24177599
[TBL] [Abstract][Full Text] [Related]
16. The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs.
Fareh S; Bénardeau A; Thibault B; Nattel S
Circulation; 1999 Nov; 100(21):2191-7. PubMed ID: 10571979
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of aliskiren on atrial ionic remodeling in a canine model of rapid atrial pacing.
Zhao Z; Wang X; Li J; Yang W; Cheng L; Chen Y; Liu T; Liu E; Chen K; Li G
Cardiovasc Drugs Ther; 2014 Apr; 28(2):137-43. PubMed ID: 24488001
[TBL] [Abstract][Full Text] [Related]
18. Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.
Li Y; Li W; Yang B; Han W; Dong D; Xue J; Li B; Yang S; Sheng L
J Electrocardiol; 2007 Jan; 40(1):100.e1-6. PubMed ID: 17067622
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective mineralocorticoid receptor antagonism on atrial ion currents and early ionic tachycardia-induced electrical remodelling in rabbits.
Laszlo R; Bentz K; Konior A; Eick C; Schreiner B; Kettering K; Schreieck J
Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):347-56. PubMed ID: 20799026
[TBL] [Abstract][Full Text] [Related]
20. Endogenous angiotensin II suppresses stretch-induced ANP secretion via AT1 receptor pathway.
Oh YB; Gao S; Shah A; Kim JH; Park WH; Kim SH
Peptides; 2011 Feb; 32(2):374-81. PubMed ID: 21056071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
